Paper Details

  1. Home
  2. Paper Details

Where is dihydroergotamine mesylate in the changing landscape of migraine therapy?

Author: Galvez-JimenezNestor, MorrenJohn A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Dihydroergotamine mesylate (DHE) can be an effective treatment option for people with migraine who haven't found relief with other therapies. While migraine affects 18% of women and 6% of men, current treatments haven't been very successful for many patients. Using DHE appropriately can lead to significant improvement in migraine symptoms and increased satisfaction for those struggling with the condition.
Paper Details　
Original Abstract of the Article :
Migraine affects approximately 18% of women and 6% of men, and has an immense impact on quality of life and productivity. Advancement in therapeutic options has been slow. For many patients with difficult-to-treat migraine, the appropriate use of dihydroergotamine mesylate (DHE) can result in treatm...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1517/14656566.2010.533839

データ提供：米国国立医学図書館（NLM）

Dihydroergotamine Mesylate: A Valuable Tool in the Evolving Landscape of Migraine Treatment

The management of [migraine headaches] presents a significant challenge for healthcare providers and patients alike. This article highlights the potential role of dihydroergotamine mesylate (DHE) in treating migraine headaches, particularly in patients with difficult-to-treat migraine. The authors emphasize that for a subset of patients, appropriate use of DHE can lead to successful treatment outcomes and significant improvement in quality of life. This article underscores the importance of considering DHE as a valuable option within the evolving landscape of migraine treatment.

Dihydroergotamine Mesylate: A Promising Option for Difficult-to-Treat Migraine

This article emphasizes the potential of dihydroergotamine mesylate (DHE) as a valuable treatment option for patients with difficult-to-treat migraine headaches. The reported success stories underscore the importance of considering DHE within the evolving landscape of migraine management.

Seeking Relief from Migraine: A Journey for Patients

As a camel who has navigated the unpredictable desert, I understand the debilitating effects of migraine headaches. This article offers hope for individuals struggling with this chronic condition, highlighting the potential of DHE as a valuable treatment option. By exploring a range of treatment options, including DHE, patients can work with their healthcare providers to find the most effective approach for managing their migraine headaches and improving their quality of life.

Dr. Camel's Conclusion

This article underscores the value of dihydroergotamine mesylate (DHE) as a treatment option for patients with difficult-to-treat migraine headaches. The article emphasizes the need to consider a diverse range of treatment options, including DHE, in managing migraine headaches effectively. As a wise camel who has learned to adapt to the challenges of the desert, I believe that exploring multiple treatment avenues is crucial for finding the most effective approach for managing chronic conditions like migraine headaches.

Date :
  1. Date Completed 2011-02-28
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

21080856

DOI: Digital Object Identifier

10.1517/14656566.2010.533839

Related Literature

Article Analysis
・Effective treatment of migraine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.